Silver Book Fact

The total economic burden of coronary heart disease is $120.6 billion; of stroke is $48.9 billion.

Cutler, David M., Genia Long, Ernst R. Berndt, Jimmy Royer, Andree-Anne Fournier, Alicia Sasser, and Pierre Cremieux. The Value Of Antihypertensive Drugs: A perspective on medical innovation. Health Affairs. 2007; 26(1): 97-110

Reference

Title
The Value Of Antihypertensive Drugs: A perspective on medical innovation
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2007
Authors
Cutler, David M., Genia Long, Ernst R. Berndt, Jimmy Royer, Andree-Anne Fournier, Alicia Sasser, and Pierre Cremieux
Volume & Issue
Volume 26, Issue 1
Pages
97-110

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Increased hospital admissions and prolonged length of stay for patients who do not undergo treatment
    Medicare severe symptomatic aortic stenosis (sSAS) patients who do not undergo treatment have an average of 1.9 hospital admissions per year and prolonged lengths of stay — 11.5 hospital days…  
  • Among adults 45 and older, between 2002 and 2003 there were over 1/2 a million hospital discharges with at least 1 coronary stent insertion procedure performed.  
  • An estimated 76.4 million Americans age 20 years and older have hypertension.  
  • Atrial fibrillation prevalence projection, 2050
    Atrial fibrillation prevalence is projected to rise to between 5.6 and 12.1 million in 2050.  
  • Within 1 year of a first stroke, 21% of men and 24% of women 40 years of age and older, were dead.